Literature DB >> 8288668

The cement mantle in total hip arthroplasty. Analysis of long-term radiographic results.

E Ebramzadeh1, A Sarmiento, H A McKellop, A Llinas, W Gogan.   

Abstract

The correlation between the thickness of the cement mantle, the medullary canal fill, and the orientation of the stem and the long-term radiographic outcome of 836 cemented femoral components in patients who had a primary total hip replacement was assessed with use of survival analysis over a twenty-one-year follow-up period. The femoral stems of hips that had a two to five-millimeter-thick cement mantle in the proximal medial region had a better outcome than stems implanted with a thicker or thinner cement mantle. Stems in femora with less than two millimeters of proximal medial cancellous bone had a better outcome than stems in femora with thicker cancellous bone. Stems that filled more than half of the medullary canal had better radiographic results than those that filled half or less. Progressive loosening, fracture of the cement, and radiolucent lines at the stem-cement or bone-cement interfaces were more likely to develop in stems that were oriented in more than 5 degrees of varus than in those in neutral or valgus. The noted correlations were true whether the stem was made of titanium alloy or of stainless steel. The results of this study emphasize the importance of careful preoperative planning in total hip arthroplasty done with cement and provide guidelines for the selection of the shape, size, and position of the stem.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8288668     DOI: 10.2106/00004623-199401000-00010

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  29 in total

1.  The femoral cement mantle in three total hip replacements.

Authors:  S J Mellor; L G Ripley; D M Ricketts
Journal:  Int Orthop       Date:  2003-10-08       Impact factor: 3.075

2.  Multi-technique characterization of retrieved bone cement from revised total hip arthroplasties.

Authors:  T Eliades; J S Papadopulos; G Eliades; N Silikas; D C Watts
Journal:  J Mater Sci Mater Med       Date:  2003-11       Impact factor: 3.896

Review 3.  [Prosthetic care of proximal femur fractures].

Authors:  F Bonnaire; T Lein; T Hohaus; A Weber
Journal:  Unfallchirurg       Date:  2005-05       Impact factor: 1.000

4.  Prediction of Charnley femoral stem aseptic loosening by early post-operative radiological features.

Authors:  M H A Malik; N Fisher; J Gray; B M Wroblewski; P R Kay
Journal:  Int Orthop       Date:  2005-08-05       Impact factor: 3.075

5.  [The cemented MS-30 stem. A multi-surgeon series of 333 consecutive cases].

Authors:  M Clauss; T Reitzel; M Pritsch; U J Schlegel; R G Bitsch; V Ewerbeck; H Mau; S J Breusch
Journal:  Orthopade       Date:  2006-07       Impact factor: 1.087

6.  [Not Available].

Authors:  W Fitz; W Gördes
Journal:  Oper Orthop Traumatol       Date:  1998-03       Impact factor: 1.154

7.  2008 Otto Aufranc Award: component design and technique affect cement penetration in hip resurfacing.

Authors:  Paul E Beaulé; Wadih Y Matar; Philippe Poitras; Kevin Smit; Olivier May
Journal:  Clin Orthop Relat Res       Date:  2008-10-16       Impact factor: 4.176

8.  Short-keeled cemented tibial components show an increased risk for aseptic loosening.

Authors:  Christian Ries; Markus Heinichen; Florian Dietrich; Eike Jakubowitz; Christian Sobau; Christian Heisel
Journal:  Clin Orthop Relat Res       Date:  2012-10-05       Impact factor: 4.176

9.  Basic science considerations in primary total hip replacement arthroplasty.

Authors:  Saqeb B Mirza; Douglas G Dunlop; Sukhmeet S Panesar; Syed G Naqvi; Shafat Gangoo; Saif Salih
Journal:  Open Orthop J       Date:  2010-05-11

10.  The posterior approach reduces the risk of thin cement mantles with a straight femoral stem design.

Authors:  Gavin J Macpherson; Christian Hank; Michael Schneider; Morag Trayner; Robert Elton; Colin R Howie; Steffen J Breusch
Journal:  Acta Orthop       Date:  2010-06       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.